Cytokine-mediated effects by granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and others also contribute to therapy resistance of FLT3-ITD-mutated AML [64]. Here, IL3 is linked to acute myeloid leukemia.